Industry
Global Antimicrobial Resistance Diagnostics Market Driven by Increasing Hospital-Acquired Infections
The global market for antimicrobial resistance diagnostics is expected to reach USD 5.7 billion by 2028, registering a CAGR of 6.1% during the forecast period 2022-2028. The market growth will be driven by the availability of better diagnostic tests and kits, as well as the increasing incidence of hospital-acquired infections. More...31 Mar 2023
Cardiac Troponin Diagnostics Market Driven by Demand for High Sensitivity POC Testing
The global market for cardiac troponin (cTn) diagnostics is expected to achieve a compound annual growth rate (CAGR) of 2.4%, reaching USD 2.28 billion by 2025 from USD 2.07 billion in 2021, driven by a rise in the number of patients with cardiac complaints visiting emergency departments and the increasing adoption of high-sensitivity POCT cTn assays by hospitals and clinical laboratories, which can detect troponin in lower concentrations and shorten the timeline for MI detection. More...27 Mar 2023
Roche and Eli Lilly Collaborate on Innovative Blood Test for Early Diagnosis of Alzheimer's
Roche has entered into a collaboration with Eli Lilly to support the development of Roche’s Elecsys Amyloid Plasma Panel (EAPP) - an innovative blood test that aims to facilitate the earlier diagnosis of Alzheimer’s disease. More...23 Mar 2023
Integra Biosciences Acquires Biotechnology Specialist Miroculus to Advance Genomics Discoveries
INTEGRA Biosciences has acquired Miroculus, a biotech company focused on developing automation solutions that streamline NGS protocols. The acquisition will allow INTEGRA to extend its reach in the growing NGS market, providing novel process automation solutions to assist academic, research and diagnostics laboratories in saving time and speeding up discovery in this dynamic field. More...20 Mar 2023
Enzo Biochem Sells Clinical Laboratory Division to Labcorp
Enzo Biochem has entered into an agreement for LabCorp Diagnostics to acquire the assets of Enzo’s Clinical Laboratory division. The deal between the two top global life sciences companies comes after several measures taken by Enzo in 2022 to further drive the company’s “focused return” initiative for maximizing shareholder value. More...20 Mar 2023
Werfen Completes Immucor Acquisition to Expand Leadership in Specialized Diagnostics
Werfen has successfully completed the acquisition of Immucor, a privately held in vitro diagnostics (IVD) company with a strong presence in the global Transfusion and Transplant markets, after receiving the required regulatory and antitrust approvals. More...16 Mar 2023
PerkinElmer Transforms into New Life Sciences & Diagnostics Company with Completion of Business Divestitures
PerkinElmer, Inc. (Waltham, MA; USA) has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses. The resulting new, high-growth Life Sciences and Diagnostics business, focused on developing and delivering novel scientific breakthroughs that is expected to have a significant impact on improving global health, will share the PerkinElmer name with the Applied, Food and Enterprise Services businesses until a new name, brand and ticker symbol is introduced in Q2 2023 pending shareholder approval. More...15 Mar 2023
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
STI Test
REALQUALITY RQ-SevenSTI
New
Mini Vortex Mixer
Vornado
In Other News
Siemens and Sysmex Sign Global Hemostasis Supply Agreement
Siemens Partners with Hamamatsu to Expand Into Digital Pathology in Americas and Europe
Global Urinalysis Market Driven by Growing Demand for Point-of-Care Diagnostic Testing
Global Microbiology Diagnostic Devices and Equipment Market Driven by Emergence of Novel Pathogens
DiaSorin’s Luminex Subsidiary to Spin Off Flow Cytometry Business to Cell Analysis Leader
Next-Generation Sequencing (NGS) Market Driven by Launch of Technologically Advanced Systems
Global Hemostasis Analyzers Market Driven by Increasing Awareness of Blood Disorder Conditions
Chembio and Biosynex to Merge, Forging US-French Point-of-Care Testing Powerhouse
CerTest to Run ‘More than Diagnostics’ Campaign Throughout 2023
New Collaboration to Apply Power of AI to Digital Pathology Images
Point-of-Care Glucose Testing Market to Reach Almost USD 6 Billion by 2032
Carolina Liquid Chemistries and Diazyme Enter Into Partnership
Siemens Launches Centre of Excellence for Immunoassay Instrument R&D in Ireland
Medlab Middle East Sees 100% Increase in Exhibitor Numbers
Thermo Fisher Completes Acquisition of UK’s Binding Site
Tianlong’s PCR Lab Solution Safeguards 2022 G20 Indonesia Summit
Tianlong Contributes to China’s Power to Prevent and Control Global Epidemics
Global Urinalysis Market Driven by Increasing Burden of UTIs, Diabetes, and Kidney & Liver Diseases
Fujifilm Enters Digital Pathology Space with Acquisition of Inspirata
Global POC Diagnostics Market Driven by Growing Demand for Portable and Handheld Near-Patient Devices
Global Microplate Readers Market Driven by Rising Incidence of Infectious Diseases
AI-Based Digital Pathology Solutions Market Driven by Benefits of More Precise and Reproducible Diagnoses
Leica Biosystems Acquires Cell IDx, Expanding Offerings in Multiplexed Tissue Profiling
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.